Comparison of Amyloid-PET Analysis Software Using 18F-Florbetaben PET in Patients with Cognitive Impairment
Diagnostics · 13.08.2025 · 15 (16) · 2028
DOI: 10.3390/diagnostics15162028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 13.08.2025. Verfasst von Miju Cheon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: VHS Medical Center Research Grant, Korean Society of Nuclear Medicine, VHS Medical Center Research Grant, Republic of Korea.
Abstract (Originalsprache)
Background/Objectives: Quantitative analysis of amyloid PET imaging plays a crucial role in diagnosing Alzheimer’s disease (AD), particularly in cases where visual interpretation is equivocal. Multiple commercial software tools are available for this purpose, yet differences in their quantification and diagnostic performance remain understudied, especially for Neurophet SCALE PET.
Methods
We retrospectively analyzed 18F-florbetaben PET/CT scans from 129 patients with cognitive impairment, comprising 39 patients with AD and 90 with non-AD diagnoses, using three software tools: MIMneuro, CortexID Suite, and Neurophet SCALE PET. Standardized uptake value ratios (SUVRs) were obtained for six brain regions known for amyloid accumulation. Diagnostic accuracy was evaluated using ROC curve analysis, while inter-software correlations and reliability were assessed via Pearson correlation coefficients and intraclass correlation coefficients (ICC).
Results
All three software programs significantly distinguished AD from non-AD patients in most brain regions. MIMneuro and Neurophet SCALE PET demonstrated the highest diagnostic performance, with MIMneuro achieving an AUC of 1.000 in the anterior cingulate gyrus. While MIMneuro and Neurophet SCALE PET showed moderate-to-strong SUVR correlations (r = 0.715–0.865), CortexID Suite showed limited correlation with the other tools. Inter-software reliability was moderate only in selected regions (ICC ≈ 0.5), indicating potential variability in SUVR measurements across platforms.
Conclusions
MIMneuro, CortexID Suite, and Neurophet SCALE PET are effective for the semi-quantitative analysis of amyloid PET and can aid in the diagnosis of AD. However, clinicians should be cautious when interpreting SUVRs across different software tools due to limited inter-software consistency. Standardization efforts or consistent use of a single platform are recommended to avoid diagnostic discrepancies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea.
- Department of Neurology, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea.
- Department of Radiology, University of California Davis, Sacramento, CA 95817, USA.
ORCID-Profile: Miju Cheon, Yasser G Abdelhafez
Förderung
- VHS Medical Center Research Grant
- Korean Society of Nuclear Medicine
- VHS Medical Center Research Grant, Republic of Korea
Zitieren
APA
Cheon, M., Yi, H., Ha, S. W., Kang, M. J., Jeong, D. E., Abdelhafez, Y. G., & Nardo, L. (2025). Comparison of Amyloid-PET Analysis Software Using 18F-Florbetaben PET in Patients with Cognitive Impairment. Diagnostics, 15(16), 2028. https://doi.org/10.3390/diagnostics15162028
Vancouver
Cheon M, Yi H, Ha SW, Kang MJ, Jeong DE, Abdelhafez YG, et al. Comparison of Amyloid-PET Analysis Software Using 18F-Florbetaben PET in Patients with Cognitive Impairment. Diagnostics. 2025;15(16):2028. doi:10.3390/diagnostics15162028
BibTeX
@article{Cheon2025,
author = {Cheon, Miju and Yi, Hyunkyung and Ha, Sang-Won and Kang, Min Ju and Jeong, Da-Eun and Abdelhafez, Yasser G and Nardo, Lorenzo},
title = {Comparison of Amyloid-PET Analysis Software Using 18F-Florbetaben PET in Patients with Cognitive Impairment},
journal = {Diagnostics},
year = {2025},
volume = {15},
number = {16},
pages = {2028},
doi = {10.3390/diagnostics15162028}
}
EUVIMED